Predictors of blood pressure response to the angiotensin receptor blocker candesartan in essential hypertension

被引:43
作者
Canzanello, Vincent J. [1 ]
Baranco-Pryor, Evelyn [2 ]
Rahbari-Oskoui, Frederic [2 ]
Schwartz, Gary L. [1 ]
Boerwinkle, Eric [3 ]
Turner, Stephen T. [1 ]
Chapman, Arlene B. [2 ]
机构
[1] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN USA
[2] Emory Univ, Sch Med, Dept Med, Div Renal, Atlanta, GA USA
[3] Univ Texas, Hlth Sci Ctr, Human Genet & Inst Mol Med, Houston, TX USA
关键词
D O I
10.1038/ajh.2007.24
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
BACKGROUND Response to anti hypertensive drugs varies widely among individuals. METHODS We studied characteristics that might be predictive of blood pressure (BP) response in 203 African-American and 236 non-Hispanic white subjects with essential hypertension treated with candesartan, 32 mg/day for 6 weeks, after a drug-free washout period of at least 4 weeks (baseline). Measurements at enrollment, baseline, and at the end of the treatment were incorporated into linear regression models to quantify their additive contributions to predicting response. RESULTS Enrollment measurements predictive of a greater response were non-Hispanic white ethnicity, female gender, the interaction between ethnicity and gender, and lower body weight. Of baseline measurements, higher BP and higher plasma renin activity (PRA) made additional contributions to predicting a greater response. Of the measurements made at the end of the study, only a larger increase in PRA from baseline contributed to predicting a greater response. The combined effects of all the identified predictors accounted for 39 and 33% of the interindividual variation in systolic and diastolic BP responses, respectively (P < 0.001 for both). CONCLUSIONS These results indicate that easily determined characteristics such as ethnicity, gender, body weight, as well as pretreatment levels of BP and PRA predict a substantial fraction of the BP response to candesartan and support the notion that characteristics associated with a poor response to diuretic therapy are associated with better responses to an angiotensin receptor blocker (ARB).
引用
收藏
页码:61 / 66
页数:6
相关论文
共 32 条
[11]   Double-blind, placebo-controlled crossover comparison of five classes of anti hypertensive drugs [J].
Deary, AJ ;
Schumann, AL ;
Murfet, H ;
Haydock, SF ;
Foo, RSY ;
Brown, MJ .
JOURNAL OF HYPERTENSION, 2002, 20 (04) :771-777
[12]   Optimisation of antihypertensive treatment by crossover rotation of four major classes [J].
Dickerson, JEC ;
Hingorani, AD ;
Ashby, MJ ;
Palmer, CR ;
Brown, MJ .
LANCET, 1999, 353 (9169) :2008-2013
[13]   Management of high blood pressure in African Americans - Consensus statement of the hypertension in African Americans Working Group of the International Society on Hypertension in Blacks [J].
Douglas, JG ;
Bakris, GL ;
Epstein, M ;
Ferdinand, KC ;
Ferrario, C ;
Flack, JM ;
Jamerson, KA ;
Jones, WE ;
Haywood, J ;
Maxey, R ;
Ofili, EO ;
Sanders, E ;
Schiffrin, EL ;
Sica, DA ;
Sowers, JR ;
Vidt, DG .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (05) :525-541
[14]  
Evans RD, 2004, IRISH J AGR FOOD RES, V43, P1
[15]  
FRAY JCS, 1993, PATHOPHYSIOLOGY HYPE
[16]   Gender affects renal vasoconstrictor response to Ang I and Ang II [J].
Gandhi, SK ;
Gainer, J ;
King, D ;
Brown, NJ .
HYPERTENSION, 1998, 31 (01) :90-96
[17]   Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000 [J].
Hajjar, I ;
Kotchen, TA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02) :199-206
[18]  
Hanatani T., 2001, Pharmacogenomics Journal, V1, P288
[19]   MODERN SYSTEM FOR TREATING HIGH BLOOD-PRESSURE BASED ON RENIN PROFILING AND VASOCONSTRICTION VOLUME ANALYSIS - PRIMARY ROLE FOR BETA BLOCKING-DRUGS SUCH AS PROPRANOLOL [J].
LARAGH, JH .
AMERICAN JOURNAL OF MEDICINE, 1976, 61 (05) :797-810
[20]   Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial [J].
Leenen, Frans H. H. ;
Nwachuku, Chuke E. ;
Black, Henry R. ;
Cushman, William C. ;
Davis, Barry R. ;
Simpson, Lara M. ;
Alderman, Michael H. ;
Atlas, Steven A. ;
Basile, Jan N. ;
Cuyjet, Aloysius B. ;
Dart, Richard ;
Felicetta, James V. ;
Grimm, Richard H. ;
Haywood, L. Julian ;
Jafri, Syed Z. A. ;
Proschan, Michael A. ;
Thadani, Udho ;
Whelton, Paul K. ;
Wright, Jackson T. .
HYPERTENSION, 2006, 48 (03) :374-384